Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Pizaccord
Active Ingredient: Pioglitazone hydrochloride 16.53mg equivalent to Pioglitazone 15mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India
Product: Pizaccord
Active Ingredient: Pioglitazone hydrochloride 33.07mg equivalent to Pioglitazone 30mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India
Product: Pizaccord
Active Ingredient: Pioglitazone hydrochloride 49.6mg equivalent to Pioglitazone 45mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India
Product: Rotarix Oral Vaccine
Active Ingredient: Live attenuated human rotavirus 1,000,000CCID50
Dosage Form: Oral Suspension
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturers: GlaxoSmithKline Biologicals SA, Parc de la Noire Epine, Wavre, Belgium
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
Dated this 20th day of March 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).